rxstatShortages › Antihemophilic Factor

Antihemophilic Factor shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Antihemophilic Factor products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 4
Reports on file
4

Reports by product

Discontinued
HELIXATE FS
250UNIT · POWDER FOR SOLUTION · BAYER HEALTHCARE LLC
DIN 02243186
Discontinued
HELIXATE FS
500UNIT · POWDER FOR SOLUTION · BAYER HEALTHCARE LLC
DIN 02243187
Discontinued
HELIXATE FS
1000UNIT · POWDER FOR SOLUTION · BAYER HEALTHCARE LLC
DIN 02243188
Discontinued
HELIXATE FS
2000UNIT · POWDER FOR SOLUTION · BAYER HEALTHCARE LLC
DIN 02308592

What's happening

One or more Antihemophilic Factor products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Antihemophilic Factor is classified under “VITAMIN K AND OTHER HEMOSTATICS” (ATC B02BD02).

Recent changes

Common questions

When will Antihemophilic Factor be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Antihemophilic Factor in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (vitamin k and other hemostatics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.